2197
COM:CLOVERBIOPHARMA
Clover Biopharmaceuticals
- Stock
Last Close
0.29
22/11 07:42
Market Cap
415.27M
Beta: -
Volume Today
981K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -657.38M - | -657.38M 0% | -2.35B 257.60% | -2.35B 0% | -568.04M 75.84% | -568.04M 0% | -657.91M 15.82% | -657.91M 0% | 325.31M 149.45% | 325.31M 0% | -394.58M 221.29% | -394.58M 0% | -47.56M 87.95% | -47.56M 0% | |
depreciation and amortization | 3.60M - | 3.60M 0% | 8.65M 140.41% | 8.65M 0% | 14.08M 62.87% | 14.08M 0% | 14.25M 1.19% | 14.25M 0% | 14.11M 0.96% | 14.11M 0% | 10.64M - | 10.64M 0% | |||
deferred income tax | 349.88M - | 647.80M 85.15% | -1.67B 357.83% | -3.53M 99.79% | -225.72M 6,293.35% | ||||||||||
stock based compensation | 17.13M - | 17.13M 0% | 45.47M 165.39% | 45.47M 0% | 31.93M 29.77% | 31.93M 0% | 15.58M 51.22% | 15.58M 0% | 11.92M 23.47% | 11.92M 0% | 14.84M 24.44% | 14.84M 0% | 3.93M 73.50% | 3.93M 0% | |
change in working capital | -10.91M - | -10.91M 0% | -965.26M 8,749.10% | -965.26M 0% | -234.45M 75.71% | -381.82M 62.86% | -663.38M 73.74% | -663.38M 0% | -8.39M 98.74% | -8.39M 0% | -21.20M - | -21.20M 0% | |||
accounts receivables | 1.44B - | -290.50K 100.02% | -290.50K 0% | 12.05M - | 12.05M 0% | ||||||||||
inventory | -68.36M - | -68.36M 0% | -317.52M 364.48% | -317.52M 0% | -381.82M 20.25% | -381.82M 0% | -663.38M 73.74% | -663.38M 0% | -8.10M 98.78% | -8.10M 0% | -840K - | -840K 0% | |||
accounts payables | -160.32M - | -130.44M - | |||||||||||||
other working capital | 57.45M - | 57.45M 0% | -647.74M 1,227.46% | -647.74M 0% | 147.37M 122.75% | -1.28B - | 130.44M - | -32.41M - | -32.41M 0% | ||||||
other non cash items | 419.79M - | 419.79M 0% | 3.03B 621.98% | 3.03B 0% | 477.11M 84.26% | 274.59M 42.45% | 77.62M 71.73% | 2.40B 2,986.39% | -554.62M 123.15% | -332.44M 40.06% | 379.75M 214.23% | 379.75M 0% | -24.77M 106.52% | -24.77M 0% | |
net cash provided by operating activities | -227.76M - | -227.76M 0% | -231.11M 1.47% | -231.11M 0% | -279.37M 20.88% | -279.37M 0% | -566.04M 102.62% | -566.04M 0% | -215.20M 61.98% | -215.20M 0% | -78.96M - | -78.96M 0% | |||
investments in property plant and equipment | -17.56M - | -17.56M 0% | -12.07M 31.25% | -12.07M 0% | -26.46M 119.23% | -26.46M 0% | -12.05M 54.44% | -12.05M 0% | -1.87M 84.46% | -1.87M 0% | -612.50K - | -612.50K 0% | |||
acquisitions net | 2.47M - | ||||||||||||||
purchases of investments | -15.63M - | ||||||||||||||
sales maturities of investments | -6.21M - | ||||||||||||||
other investing activites | 6.80M - | 6.80M 0% | 78.89M 1,060.58% | 78.89M 0% | 31.39M 60.21% | 31.39M 0% | -11.63M 137.05% | 7.74M 166.58% | -534.50K 106.90% | -534.50K 0% | -3.89M - | -3.89M 0% | |||
net cash used for investing activites | -10.76M - | -10.76M 0% | 66.82M 721.09% | 66.82M 0% | 4.93M 92.62% | 4.93M 0% | -23.68M 580.23% | -23.68M 0% | -2.41M 89.83% | -2.41M 0% | -4.51M - | -4.51M 0% | |||
debt repayment | -1.99M - | -11.74M - | -329.70M - | -120.02M - | |||||||||||
common stock issued | 502.90M - | 15.83K - | |||||||||||||
common stock repurchased | |||||||||||||||
dividends paid | |||||||||||||||
other financing activites | 736.17M - | 738.16M 0.27% | 792.42M 7.35% | 792.42M 0% | -7.15M 100.90% | -7.15M 0% | 248.72M 3,577.68% | 75.53M 69.63% | 39.64M 47.52% | 159.64M 302.74% | -55.94M - | -55.94M 0% | |||
net cash used provided by financing activities | 736.17M - | 736.17M 0% | 792.42M 7.64% | 792.42M 0% | -7.15M 100.90% | -7.15M 0% | 248.72M 3,577.68% | 248.72M 0% | 39.64M 84.06% | 39.64M 0% | -55.94M - | -55.94M 0% | |||
effect of forex changes on cash | -3.63M - | -3.63M 0% | 3.45M 195.03% | 3.45M 0% | 25.72M 644.69% | 25.72M 0% | 16.88M 34.36% | 16.88M 0% | 6.49M 61.57% | 6.49M 0% | 867K - | 867K 0% | |||
net change in cash | 494.01M - | 494.01M 0% | 631.58M 27.85% | 631.58M 0% | -255.86M 140.51% | -255.86M 0% | -324.12M 26.68% | -579.52M 78.80% | -171.48M 70.41% | -441.35M 157.38% | -138.54M - | -138.54M 0% | |||
cash at beginning of period | 1.01B - | 1.50B 48.90% | 2.51B - | 2.26B 10.19% | 2.66B 17.95% | 2.08B - | |||||||||
cash at end of period | 494.01M - | 1.50B 204.49% | 2.14B 41.99% | 631.58M 70.43% | -255.86M 140.51% | 2.26B 981.58% | 1.93B 14.37% | 2.08B 7.74% | -171.48M 108.24% | 1.64B 1,056.24% | -138.54M - | -138.54M 0% | |||
operating cash flow | -227.76M - | -227.76M 0% | -231.11M 1.47% | -231.11M 0% | -279.37M 20.88% | -279.37M 0% | -566.04M 102.62% | -566.04M 0% | -215.20M 61.98% | -215.20M 0% | -78.96M - | -78.96M 0% | |||
capital expenditure | -17.56M - | -17.56M 0% | -12.07M 31.25% | -12.07M 0% | -26.46M 119.23% | -26.46M 0% | -12.05M 54.44% | -12.05M 0% | -1.87M 84.46% | -1.87M 0% | -612.50K - | -612.50K 0% | |||
free cash flow | -245.32M - | -245.32M 0% | -243.18M 0.87% | -243.18M 0% | -305.83M 25.76% | -305.83M 0% | -578.09M 89.03% | -578.09M 0% | -217.07M 62.45% | -217.07M 0% | -79.58M - | -79.58M 0% |
All numbers in (except ratios and percentages)